Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

Elisabetta Moscarella; Attilio Varricchio; Eugenio Stabile; Azeem Latib; Alfonso Ielasi; Maurizio Tespili; Bernardo Cortese; Paolo Calabrò; Francesco Granata; Vasileios F. Panoulas; Anna Franzone; Bruno Trimarco; Giulio Bonzani; Giovanni Esposito; Antonio Colombo

doi:10.1016/j.ijcard.2015.07.002

Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

Elisabetta Moscarella, Attilio Varricchio, Eugenio Stabile, Azeem Latib, Alfonso Ielasi, Maurizio Tespili, Bernardo Cortese, Paolo Calabrò, Francesco Granata, Vasileios F. Panoulas, Anna Franzone, Bruno Trimarco, Giulio Bonzani, Giovanni Esposito, Antonio Colombo

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.

Original language	English (US)
Pages (from-to)	366-372
Number of pages	7
Journal	International Journal of Cardiology
Volume	199
DOIs	https://doi.org/10.1016/j.ijcard.2015.07.002
State	Published - Sep 15 2015
Externally published	Yes

Keywords

BVS
DES
Restenosis
Stent

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2015.07.002

Cite this

Moscarella, E., Varricchio, A., Stabile, E., Latib, A., Ielasi, A., Tespili, M., Cortese, B., Calabrò, P., Granata, F., Panoulas, V. F., Franzone, A., Trimarco, B., Bonzani, G., Esposito, G., & Colombo, A. (2015). Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. International Journal of Cardiology, 199, 366-372. https://doi.org/10.1016/j.ijcard.2015.07.002

Moscarella, E, Varricchio, A, Stabile, E, Latib, A, Ielasi, A, Tespili, M, Cortese, B, Calabrò, P, Granata, F, Panoulas, VF, Franzone, A, Trimarco, B, Bonzani, G, Esposito, G & Colombo, A 2015, 'Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience', International Journal of Cardiology, vol. 199, pp. 366-372. https://doi.org/10.1016/j.ijcard.2015.07.002

@article{fa7c3ac2684248fc8fe29bab92ed6bfe,

title = "Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience",

abstract = "This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.",

keywords = "BVS, DES, Restenosis, Stent",

author = "Elisabetta Moscarella and Attilio Varricchio and Eugenio Stabile and Azeem Latib and Alfonso Ielasi and Maurizio Tespili and Bernardo Cortese and Paolo Calabr{\`o} and Francesco Granata and Panoulas, {Vasileios F.} and Anna Franzone and Bruno Trimarco and Giulio Bonzani and Giovanni Esposito and Antonio Colombo",

year = "2015",

month = sep,

day = "15",

doi = "10.1016/j.ijcard.2015.07.002",

language = "English (US)",

volume = "199",

pages = "366--372",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis

T2 - Results from a multicenter Italian experience

AU - Moscarella, Elisabetta

AU - Varricchio, Attilio

AU - Stabile, Eugenio

AU - Latib, Azeem

AU - Ielasi, Alfonso

AU - Tespili, Maurizio

AU - Cortese, Bernardo

AU - Calabrò, Paolo

AU - Granata, Francesco

AU - Panoulas, Vasileios F.

AU - Franzone, Anna

AU - Trimarco, Bruno

AU - Bonzani, Giulio

AU - Esposito, Giovanni

AU - Colombo, Antonio

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.

AB - This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.

KW - BVS

KW - DES

KW - Restenosis

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=84941662896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941662896&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2015.07.002

DO - 10.1016/j.ijcard.2015.07.002

M3 - Article

C2 - 26241643

AN - SCOPUS:84941662896

SN - 0167-5273

VL - 199

SP - 366

EP - 372

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this